|
CTNM Contineum Therapeutics Inc 1855175 |
| Income Statement |
|
Net Income
|
2026-03-31
|
$-14,456,000.00 |
| Balance Sheet |
|
Current Assets
|
$252,964,000.00 |
|
Assets
|
$261,349,000.00 |
|
Current Liabilities
|
$6,657,000.00 |
|
Liabilities
|
$11,308,000.00 |
|
Equity
|
$250,041,000.00 |
|
Shares Out
|
2384426.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-16,266,000.00 |
|
Investing Cash Flow
|
$-39,308,000.00 |
| Market Analysis |
Market Cap
|
$37,554,709.50 |
|
Price
|
$15.27 |
|
BVPS
|
104.86 |
|
PB
|
0.15 |
|
EPS
|
-0.39 |
|
FCF
|
$-16,578,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:29 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:01:26 |
|
| Apr |
May |
Jun |
| 2026-03-05 |
-0.49 |
|
|
2026-05-05 |
-0.39 |
|
| Jul |
Aug |
Sep |
|
|
|
|
2025-08-05 |
-0.62 |
|
| Oct |
Nov |
Dec |
|
|
2025-10-30 |
-0.45 |
|
|
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view CTNM documents filed with the SEC.
CTNM Filings
Clear
